CN1220601A - 抗病毒化合物 - Google Patents

抗病毒化合物 Download PDF

Info

Publication number
CN1220601A
CN1220601A CN97195098A CN97195098A CN1220601A CN 1220601 A CN1220601 A CN 1220601A CN 97195098 A CN97195098 A CN 97195098A CN 97195098 A CN97195098 A CN 97195098A CN 1220601 A CN1220601 A CN 1220601A
Authority
CN
China
Prior art keywords
alkyl
chemical compound
pharmaceutically acceptable
hydrogen
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97195098A
Other languages
English (en)
Chinese (zh)
Inventor
L·N·琼黑姆
T·A·舍菲尔德
W·A·斯皮策尔
M·J·特贝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1220601A publication Critical patent/CN1220601A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN97195098A 1996-06-05 1997-06-05 抗病毒化合物 Pending CN1220601A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1917096P 1996-06-05 1996-06-05
US60/019,170 1996-06-05

Publications (1)

Publication Number Publication Date
CN1220601A true CN1220601A (zh) 1999-06-23

Family

ID=21791797

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97195098A Pending CN1220601A (zh) 1996-06-05 1997-06-05 抗病毒化合物

Country Status (9)

Country Link
EP (1) EP0906097A4 (de)
JP (1) JP2000511899A (de)
KR (1) KR20000016346A (de)
CN (1) CN1220601A (de)
AU (1) AU3212897A (de)
BR (1) BR9709528A (de)
CA (1) CA2257296A1 (de)
EA (1) EA001316B1 (de)
WO (1) WO1997046237A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
CA2293508A1 (en) * 1997-06-04 1998-12-10 Louis Nickolaus Jungheim Anti-viral compounds
WO1999059587A1 (en) * 1998-05-20 1999-11-25 Eli Lilly And Company Anti-viral compounds
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
TR200103147T1 (tr) * 1999-12-27 2002-06-21 Japan Tobacco Inc. Kaynaşık halkalı bileşikler ve bunların ilaç olarak kullanımı.
EP1651631A1 (de) 2003-08-01 2006-05-03 Genelabs Technologies, Inc. Bicyclische imidazolderivate gegen flaviviridae
JP4143669B2 (ja) 2004-02-24 2008-09-03 日本たばこ産業株式会社 ４環縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434288A (en) * 1982-04-08 1984-02-28 Eli Lilly And Company Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4420479A (en) * 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles

Also Published As

Publication number Publication date
EA001316B1 (ru) 2001-02-26
EA199801078A1 (ru) 1999-04-29
BR9709528A (pt) 1999-08-10
AU3212897A (en) 1998-01-05
KR20000016346A (ko) 2000-03-25
WO1997046237A1 (en) 1997-12-11
CA2257296A1 (en) 1997-12-11
JP2000511899A (ja) 2000-09-12
EP0906097A4 (de) 2000-12-13
EP0906097A1 (de) 1999-04-07

Similar Documents

Publication Publication Date Title
CN1034216C (zh) 7-(取代)-9-[(取代甘氨酰)酰氨基]-6-脱甲基-6-脱氧四环素
CN1220602A (zh) 抗病毒化合物
CN1052010C (zh) 苯并咪唑衍生物及其制备方法和用途以及含该衍生物的药物制剂
CN1026984C (zh) 偏端霉素衍生物的制备方法
CN1129597C (zh) 杂环化合物和以其为有效成分的抗肿瘤剂
CN1034072C (zh) 四氢咔唑衍生物的制备方法
CN1149870A (zh) 具有促皮质激素释放因子拮抗剂活性的取代的吡唑
CN1922181A (zh) 通过使用咪唑并[1,2－b]哒嗪衍生物控制动物中的寄生虫
CN1033043A (zh) 新的抗抑郁剂的制法
EA032546B1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
CN1220601A (zh) 抗病毒化合物
CN1220603A (zh) 抗病毒化合物
CN1068587C (zh) 邻位取代的苯甲酸衍生物
CN1243545C (zh) 切割dna的抗肿瘤剂
CN1240419A (zh) 具有nos抑制作用的芳香族胺衍生物
CN1147297C (zh) 新型七叶亭衍生物及医药组合物
CN1166623C (zh) 2-苯氧基苯胺类衍生物
CN1743316A (zh) 2－取代苯基－4,4,5,5－四甲基－1,3－二氧基咪唑啉，它们的制备及在药物制备中的应用
CN1046334A (zh) 新的2′-卤代亚甲基、2′-亚乙烯基和2′-乙炔基腺苷衍生物
CN1045774A (zh) 有关5-羟色腰拮抗药的改进
CN1652759A (zh) 小分子进入抑制剂
CN1101644A (zh) 噻二嗪酮
CN1280279C (zh) 双苯并异唑酮类化合物及其合成和应用
CN1633411A (zh) 用于调节细胞增生的化合物
CN1063438C (zh) 链烯基-苯甲酰胍衍生物及其制备和用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication